Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013 (2013), Article ID 379641, 8 pages
Review Article

New Therapeutics to Treat Castrate-Resistant Prostate Cancer

1VKF American Hospital, Guzelbahce sokak, Nisantasi, Istanbul 34365, Turkey
2School of Medicine, Koç University, Rumelifeneri Yolu, Sariyer, Istanbul 34450, Turkey

Received 7 February 2013; Accepted 9 May 2013

Academic Editors: M. Fishman and S. Srinivas

Copyright © 2013 Ömer Acar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [13 citations]

The following is the list of published articles that have cited the current article.

  • Jill A. Trendel, “The hurdle of antiandrogen drug resistance: drug design strategies,” Expert Opinion on Drug Discovery, vol. 8, no. 12, pp. 1491–1501, 2013. View at Publisher · View at Google Scholar
  • Nicolas Mottet, Noel Clarke, Maria De Santis, Filiberto Zattoni, Juan Morote, and Steven Joniau, “Implementing newer agents for the management of castrate-resistant prostate cancer: what is known and what is needed?,” BJU International, 2014. View at Publisher · View at Google Scholar
  • Yongjiang Yu, Yu Zhang, Wenbin Guan, Tao Huang, Jian Kang, Xujun Sheng, and Jun Qi, “Androgen Receptor Promotes the Oncogenic Function of Overexpressed Jagged1 in Prostate Cancer by Enhancing Cyclin B1 Expression via Akt Phosphorylation,” Molecular Cancer Research, vol. 12, no. 6, pp. 830–842, 2014. View at Publisher · View at Google Scholar
  • Louis Gauthier-Landry, Alain Bélanger, and Olivier Barbier, “Multiple roles for udp-glucuronosyltransferase (UGT)2B15 and UGT2B17 enzymes in androgen metabolism and prostate cancer evolution,” The Journal of Steroid Biochemistry and Molecular Biology, 2014. View at Publisher · View at Google Scholar
  • Daniel P. Petrylak, Jitendra G. Gandhi, William R. Clark, Elisabeth Heath, Jianqing Lin, William K. Oh, David B. Agus, Bradley Carthon, Susan Moran, Ning Kong, Ajit Suri, Michael Bargfrede, and Glenn Liu, “Phase 1/2 study of orteronel (TAK-700), an investigational 17,20-lyase inhibitor, with docetaxel-prednisone in metastatic castration-resistant prostat,” Investigational New Drugs, vol. 33, no. 2, pp. 397–408, 2015. View at Publisher · View at Google Scholar
  • Shu Fang Soh, Xiaoxing Yin, Jiaquan Sun, Jun Li, Eu Leong Yong, Qunli Wei, and Yinhan Gong, “Simultaneous determination of multiple androgens in mice organs with liquid chromatography tandem mass spectrometry,” Journal of Pharmaceutical and Biomedical Analysis, vol. 115, pp. 457–466, 2015. View at Publisher · View at Google Scholar
  • Gaurav Joshi, Pankaj Kumar Singh, Arvind Negi, Anil Rana, Sandeep Singh, and Raj Kumar, “Growth factors mediated cell signalling in prostate cancer progression: Implications in discovery of anti-prostate cancer agents,” Chemico-Biological Interactions, vol. 240, pp. 120–133, 2015. View at Publisher · View at Google Scholar
  • Isabel Cunningham, and Brigett Kohno, “ 18 FDG-PET/CT: 21st century approach to leukemic tumors in 124 cases ,” American Journal of Hematology, 2016. View at Publisher · View at Google Scholar
  • Yu Zhou, Jiang Wang, Zhanni Gu, Shuni Wang, Wei Zhu, José Luis Aceña, Vadim A. Soloshonok, Kunisuke Izawa, and Hong Liu, “Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas,” Chemical Reviews, 2016. View at Publisher · View at Google Scholar
  • Renliang Yi, Baoxin Chen, Peng Duan, Chanjiao Zheng, Huanyu Shen, Qun Liu, Chen Yuan, Weilin Ou, and Zhiheng Zhou, “Sipuleucel-T and Androgen Receptor-Directed Therapy for Castration-Resistant Prostate Cancer: A Meta-Analysis,” Journal of Immunology Research, vol. 2016, pp. 1–10, 2016. View at Publisher · View at Google Scholar
  • Leyuan Liu, Guibin Xu, Yiming Lai, Xianju Chen, Fei Yue, Hai Huang, Kaiwen Li, Tao Du, Xinxing Fan, Wenjiao Li, and Qi Li, “Matrine suppresses invasion of castration-resistant prostate cancer cells by downregulating MMP-2/9 via NF-κB signaling pathway,” International Journal of Oncology, vol. 50, no. 2, pp. 640–648, 2017. View at Publisher · View at Google Scholar
  • Subramanyam Dasari, Guoxing Zheng, Venkata Satish Dontaraju, Maarten C. Bosland, Syed M. Ali, Aoshuang Chen, Andre Kajdacsy-Balla, and Gnanasekar Munirathinam, “Vitamin K and its analogs: Potential avenues for prostate cancer management,” Oncotarget, vol. 8, no. 34, pp. 57782–57799, 2017. View at Publisher · View at Google Scholar
  • Haofeng Zheng, Jialiang Chen, Wenhan Qiu, Sijie Lin, Yanxiong Chen, Guancan Liang, and Youqiang Fang, “Safety and Efficacy of First-Line Treatments for Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Indirect Comparison,” BioMed Research International, vol. 2017, pp. 1–10, 2017. View at Publisher · View at Google Scholar